Connect with us

Health & Wellness

COVID-19’s Cost on Lung Cancer Progress- Report

Published

on

A new report launched today at the Davos Agenda week is calling upon governments to focus urgent attention on restoring lung cancer diagnosis and treatment in order to reduce further avoidable deaths.

The report, Learning Lessons from Across Europe – Prioritising Lung Cancer after COVID-19, highlights how, in just 12 months of the pandemic, lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely the longer the pandemic continues.

Lung cancer is the largest cause of cancer deaths around the world, with over one million deaths per year. Exacerbating this impact, over 40% of countries report a complete or partial disruption to lung cancer services due to the pandemic. In response, the Lung Ambition Alliance and the World Economic Forum have launched a series of recommendations for governments and regulators on how to improve the short- and long-term resilience of lung cancer services, to ultimately improve patient outcomes.

The report was produced by the World Economic Forum and the Lung Ambition Alliance and supported by AstraZeneca in partnership with the International Association for the Study of Lung Cancer (IASLC), the Global Lung Cancer Coalition (GLCC) and Guardant Health.

Arnaud Bernaert, Head of Health and Healthcare at the World Economic Forum said: “Producing and rolling out a COVID-19 vaccine within one year required public-private cooperation on a global scale – it showed what we can do together. This report highlights policy priorities that can be put into place so cancer patients can access the care they need. The pandemic has strained our health and health systems, but there are lessons that can be applied in parallel with treating COVID-19. We hope that the public and private sectors can work together in the year ahead.”

David Baldwin, Chair, UK Clinical Expert Group for Lung Cancer and Mesotheliomaand Report Taskforce member says, “We clinicians are seeing similar late presentations of lung cancer to those that were the norm 20 years ago. With disruptions at an unprecedented level, lung cancer patients simply can’t afford to have the clock wound back to where things were. We must redouble our efforts to diagnose patients early, by urgently restoring awareness and early diagnosis campaigns, rapid diagnostic and treatment pathways and approval of national lung cancer screening programmes. Patients deserve fresh investment and services to make up for lost time and accelerate innovation in lung cancer treatment options.”

Report recommendations

Learning lessons from across Europe – prioritising lung cancer after COVID-19 makes the following recommendations:

In the short term:

· Symptom identification: The public and healthcare professionals need better information about how to spot the differences between COVID-19 and lung cancer so that people know which services to access

· Reassurance on safety: Patients need reassuring that services are safe for them to access and so there needs to be investment in COVID-19-free clinical spaces, with appropriate communication about how services are being kept safe

· Public awareness: There needs to be public health information campaigns about lung cancer to raise the public’s awareness of the signs and symptoms of lung cancer, and encourage them to seek help if they are concerned about their health

In the longer term:

· Screening and diagnosis: There needs to be investment in strategies to identify lung cancer patients more proactively, such as targeted screening programmes for those people at risk

· Robust data: Real time data collection and analysis is needed at a national and local level to identify and address the impact of COVID-19 on lung cancer patients

· Primary care capacity: There needs to be investment in capacity at a primary care level to ensure all patients with suspected lung cancer can be swiftly referred to specialist care

The report was developed by the World Economic Forum, who, in partnership with the Lung Ambition Alliance, launched a COVID-19 Taskforce in early 2020 amidst the outbreak of the pandemic.

Leading experts in health care provision, patient representation, policy and industry from across Europe (France, Germany, Italy, Spain, the United Kingdom) met regularly to discuss the current global healthcare environment and plan for the future in improving the resilience of lung cancer services.

Continue Reading
Comments

Health & Wellness

Clarity still needed on effectiveness of COVID-19 vaccine passports

Published

on

Being vaccinated against COVID-19 may not prevent transmission and vaccination passports may not be an “effective strategy” for restarting travel, the World Health Organization (WHO) cautioned on Tuesday.

“At this stage, we would not like to see vaccination passports as a requirement for entry or exit because we are not sure at this stage that the vaccine prevents transmissions,” said WHO spokesperson Dr Margaret Harris, just ahead of World Health Day on 7 April 2021.

Supply and demand

Dr. Harris added that vaccine passports may not be an effective strategy as “not everyone has access to vaccines and there are groups in society who are excluded…We are still waiting on adequate supplies to provide the vaccines to all the countries that need them.”

Highlighting how COVID-19 has impacted some people more than others, Dr. Harris said that the virus “has really exposed the stark inequities in access to and coverage of health services…Groups who already faced discrimination, poverty, social exclusion, difficult living and working conditions were the hardest hit by the pandemic”.

World Health Day plea

For this year’s World Health Day, the UN agency has urged countries to build a fairer, healthier world post-COVID-19. Dr. Harris called for action to “put in place policies and allocate resources so the most vulnerable groups can see their condition improve faster”.

This means “improving living conditions for all”, tackling “poverty and health inequities”, building sustainable societies and strong economies, and promoting “a more equitable sharing of resources, ensuring food security and nutrition” and turning “the tide on climate change”.  There is so much work to do”, she said.

Latest WHO data from Tuesday 6 March at the time of posting, indicates that there have been 131,309,792 confirmed cases of COVID-19, including 2,854,276 deaths globally, reported to WHO.

By the end of 5 April, a total of 604,032,357 vaccine doses have been administered.

Regionally, infections and deaths remain highest in the Americas, with 56,880,123 million confirmed cases, followed by Europe (46,085,310 million), South-East Asia (15,438,907), Eastern Mediterranean (7,785,717), Africa (3,126,037) and Western Pacific (1,992,953).

Continue Reading

Health & Wellness

How a Digital Algorithm is Helping Doctors Treat COVID-19 Patients

Published

on

Moscow’s backup hospitals and inpatient clinics for treatment of the coronavirus infection have started using a new solution as part of the unified digital healthcare platform. The News2 app, which is integrated into the Unified Medical Information and Analysis System (EMIAS), helps physicians assess the severity of a patient’s COVID-19 symptoms and risks of deterioration, and suggests adjustments to treatment tactics where necessary.

The system is operated on tablets with specialized software. These allow medics to read the QR codes on a patient’s hospital identification bracelet or on an identification sheet in an inpatient clinic and enter data on their condition: heart rate, blood oxygen saturation level, blood pressure, body temperature, and respiration rate. The system then calculates the result and assigns the patient to a risk group, highlighting the relevant category with a specific color.

The patient’s risk score is entered in their electronic medical record. Physicians can then review both the patient’s current integrated risk score on the international NEWS2 scale and any changes to it at any time, together with the baseline data used to generate the information. Use of this clinical scale significantly improves patient safety, ensuring that examinations are conducted at predetermined time intervals and that specific indicators are measured, resulting in timely and optimal adjustments to patient therapy.

The benefits of the system for physicians are obvious: when the risk score increases from 3 to 5, for instance, the clinician can simply decide whether more treatment is necessary or, conversely, satisfy himself that the treatment is effective if the score subsequently falls.

The NEWS2 scale is used around the world to assess the severity of a patient’s condition by interpreting results based on a sum of scores. These are used to generate a final score for assigning the patient to a specific risk group.

Digital solutions in Moscow’s healthcare sector are being implemented jointly by the city’s Department of Health and Department of Information Technology.

Continue Reading

Health & Wellness

COVID-19 origins report inconclusive: We must ‘leave no stone unturned’

Published

on

research coronavirus

The report from a team of international scientists assembled by the World Health Organization (WHO) to examine how COVID-19 first spread to humans was published on Tuesday, and was described by the UN health agency’s chief as a welcome start, but far from conclusive.

“This report is a very important beginning, but it is not the end”, said WHO Director-General, Tedros Adhanom Ghebreyesus. “We have not yet found the source of the virus, and we must continue to follow the science and leave no stone unturned as we do.”

He welcomed the findings of the 34-member team, which in January, visited the Chinese city of Wuhan where the first cases of the then new coronavirus came to light at the end of 2019.

But the WHO chief was clear that overall, it raises “further questions that will need to be addressed by further studies, as the team itself notes in the report.”

He noted that although much data had been provided, to fully understand the earliest cases, they would need access from Chinese authorities “to data including biological samples from at least September” 2019.

“In my discussions with the team, they expressed the difficulties they encountered in accessing raw data. I expect future collaborative studies to include more timely and comprehensive data sharing.”

Animal markets’ role, ‘still unclear’

Tedros welcomed the recommendations for further studies to understand the earliest human cases and clusters, and to trace animals sold at markets in and around Wuhan, but “the role of animal markets is still unclear.”

The team confirmed there had been widespread contamination in the large market of Huanan but could not determine the source of this contamination.

“Again, I welcome the recommendations for further research, including a full analysis of the trade in animals and products in markets across Wuhan, particularly those linked to early human cases”, he said.

He agreed that farmers, suppliers and their contacts should be interviewed, and that more study was needed to identify what role “farmed wild animals may have played in introducing the virus to markets in Wuhan and beyond.”

Lab leak theory not ruled out

The team also visited several laboratories in Wuhan and considered the possibility that the virus had entered the human population as a result of a laboratory incident, noted Tedros.

“However, I do not believe that this assessment was extensive enough. Further data and studies will be needed to reach more robust conclusions”, he said.

“Although the team has concluded that a laboratory leak is the least likely hypothesis, this requires further investigation, potentially with additional missions involving specialist experts, which I am ready to deploy.”

As far as WHO is concerned “all hypotheses remain on the table”, he told the Member State briefing on the report in Geneva.

“Finding the origin of a virus takes time and we owe it to the world to find the source so we can collectively take steps to reduce the risk of this happening again. No single research trip can provide all the answers.”

Continue Reading

Publications

Latest

Economy14 mins ago

Future of Work: Next Election Agenda 2022

During the last millennia, never ever before did the global populace ended up inside one single test tube? Observe, the...

Intelligence2 hours ago

COVID-19 As an Agent of Change in World Order

The Coronavirus Disease 2019 (COVID-19) pandemic has claimed millions of lives. It has severely damaged the economy of the world....

Africa4 hours ago

Scaling Up Development Could Help Southern African leaders to Defeat Frequent Miltant Attacks

Leaders of the Southern African Development Community (SADC) are now considering, without foreign interference, tackling frequent insurgency devastating regional development,...

Middle East6 hours ago

Israel and Turkey in search of solutions

Twelve and eleven years have elapsed since the Davos and Mavi Marmara incidents, respectively, and Turkey-Israel relations are undergoing intense...

Eastern Europe8 hours ago

Peace, Problems and Perspectives in the Post-war South Caucasus

The Second Karabakh War ended with the signing of the trilateral declaration between Armenia, Azerbaijan, and Russia on November 10,...

Europe12 hours ago

Vienna Process: Minilateralism for the future of Europe and its strategic neighbourhood

On the historic date of March 08th – International Women’s Day, a large number of international affairs specialists gathered for...

Reports16 hours ago

Wide Variations in Post-COVID ‘Return to Normal’ Expectations

A new IPSOS/World Economic Forum survey found that almost 60% expect a return to pre-COVID normal within the next 12...

Trending